Atorvastatin (Lestavor)
Atorvastatin
Activo Health (Pty) Ltd
Registration
- Applicant
- Activo Health (Pty) Ltd
- Certificate holder
- Activo Health (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lestavor 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10Film-coated tablets | 44105844/7.5/1058Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20Film-coated tablets | 44105944/7.5/1059Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40Film-coated tablets | 44106044/7.5/1060Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80Film-coated tablets | 44106144/7.5/1061Approved 13 December 2023 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Atorvastatin
Consolidated Schedules 06 July 2026, line 5376
S4: Ezetimibe
Consolidated Schedules 06 July 2026, line 6302
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Drag to rotate. Structure from PubChem CID 60823.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.